1. Fibrin clots obtained from diluted human plasma with bovine thrombin often contain amounts of phospholipids that cannot be diminished by further plasma dilution. 2. The 'cold insoluble residue' obtained during fibrinogen preparation has a higher phosphorus content than the purified fibrinogen. 3 . Evidence showed that adsorption of phospholipids or phosphorus-containing fibrinopeptides on purified fibrinogen or fibrin was unlikely. 4. O-Phosphorylserine was detected in acid hydrolysates of human fibrin. 5. On the basis of phosphorus determinations the average molecular weight of human fibrinogen cannot be less than 342000 (304000-383000) for a group of ten donors, and 265000 for two other persons, assuming 1 phosphorus atom/molecule and incomplete splitting of the phosphoruscontaining fibrinopeptide. Complete splitting of the phosphopeptide would require molecular weights twice as high. 6. Fibrinolysis was a possible cause of lower phosphorus contents found in isolated fibrinogen and fibrin from a donor who showed apprehension during blood collection and in a fibrinogen preparation that had been submitted to prolonged dialysis.
The presence of phosphorus in fibrin was first reported byMulder (1838) . The phosphorus content of mammalian fibrinogens and fibrins has been determined by Dmochowski & Krajewski (1961) , Fantl & Ward (1962) , Blomback, Blomback & Searle (1963) and Krajewski & Dmochowski (1963 Kekwick, Mackay, Nance & Record (1955) , the only alteration being that in the final precipitation step 0 2M-Na2HPO4 was replaced by 01-mNa2CO3. In some cases the insoluble residue remaining from the extraction of fraction F.1W with citrate buffer, pH6-18 and 10*3, at 0-2°was retained for analysis. This is referred to below as the 'cold insoluble residue'. Occasionally the ethanol precipitation method of Blomback & Blomback (1956) was used. In some preparations 6-amino-n-hexanoic acid, an inhibitor of fibrinolysis, was added to plasma.
Although only reagents of analytical grade were used it was found necessary to check that NaCl was phosphorusfree, since one brand added 1,ug. of phosphorus to fibrin clots prepared in 500ml. of 0 15m-NaCl.
Bovine thrombin (topical: Parke, Davis and Co. Ltd., Detroit, Mich., U.S.A.) was purified by dissolving and dialysing against distilled water for 1 day at 20. The sediment was discarded after centrifugation at 35000g at 4°. This preparation is referred to below as partially purified.
It contained approx. 2 5p,g. of phosphorus/500 unite of thrombin. For further purification it was freeze-dried and fractionated in a column of Amberlite IRC-50 according to the procedure of Rasmussen (1955) . Inorganic phosphate was removed by dialysing against distilled water, freezedrying and filtering through a column of Sephadex G-25 in 0-lmrNaCl. The preparation contained 0-03,ug. of phosphorus/500 units of thrombin.
Determination ofphosph-orus. Phosphorus was determined by the method of Allen (1940) , with the addition of extra acid as described by Fantl & Ward (1962) . When the NaCl concentration was greater than 0-6m the technique of Berenblum & Chain (1938) was used.
Measurement of radioactivity. For the measurement of radioactivity the materials were dissolved in 0-5ml. of N-NaOH and evaporated to dryness in stainless-steel planchets. Counting was carried out in a gasflow counter (model D-47; Nuclear-Chicago Corp., Des Plaines, Ill., U.S.A.).
Determination of protein and clottability of fibrinogen. Protein in fibrinogen and fibrin was determined from the 886 extinction at 282m,u in N-NaOH and correction for nonspecific absorption was made as described by Goodwin & Morton (1946) . The clottability of fibrinogen was determined in 0-15ms-NaCl; thrombin was added at room temperature to give a clotting time of 15-30sec. After lhr. fibrin was collected on a glass rod, squeezed free of fluid and washed with 0-15M-NaCl until protein-free. Fibrin was weighed if the amount was greater than 10mg.; the clots were prepared as above, washed with 0-15M-NaCl and with distilled water and extracted repeatedly with boiling ethanol-diethyl ether (3:1, v/v). Fibrin was dried at 1050 to constant weight over magnesium perchlorate. The following characteristics were used for the calculations.
Human fibrininN-NaOH has anE1" value at 282m, of 17-0 (mean of determinations performed at least in duplicate, and usually in triplicate, on samples from ten persons; variation +0-44). Human fibrin dissolved in 8M-urea, pH8-07, had an E101% value at 282m, of 15-3. The ultraviolet absorption of bovine fibrinogen is 2% lower than that of fibrin at 282mp (Blomback, 1958 (Lorand, 1952) .
Chromatography. Chromatography of fibrin hydrolysates for phosphorus compounds was carried out according to the procedure of Heald (1958) . The hydrolysate was fractionated on a column of Dowex 50W (X4; 100-200 mesh). Fractions were eluted with 0-05N-HCI and analysed for inorganic phosphorus and, after ashing, for organic phosphorus.
RESULTS
Results of determinations of phosphorus in human fibrinogen and fibrin are given in Table 1 , which shows that 1 g.atom of phosphorus was present in 342000g. of fibrinogen (range 304000-383000) and in 603000g. of fibrin (range 509000-696 000). In two further preparations with a clottability of 93-95 %, 1 g.atom of phosphorus was present in 265000g. of fibrinogen and in 450000g. of fibrin. Table 2 , which shows that on average 53% of the radioactivity of the isolated fibrinogen was present in fibrin and 39% was recovered in the clot liquor.
Fibrin has the property of adsorbing other compounds. In the belief that dilution would decrease adsorption the phosphorus content of fibrin ob- t 6-Amino-n-hexanoic acid was added to the blood during collection to give a concentration of 0-035M in the plasma; a concentration of 01 OM was maintained throughout the isolation. Table 3 indicate, first, that fibrin clots prepared from either concentrated or dilute solutions contained approximately the same amount of phosphorus and, secondly, that this was not significantly altered by solution of fibrin in monochloroacetic acid and precipitation by dilution and addition of trichloroacetic acid. Table 4 gives results obtained in fibrin clots formed at various dilutions of plasma. The phosphorus determinations were carried out on the clots after extraction in boiling ethanol-diethyl ether (3:1, v/v). The phosphorus-containing compounds were co-precipitated with fibrin and this could not be abolished by even higher dilution. The ethanolether-soluble material consisted of compounds characteristic of lipoprotein components. This was established by thin-layer chromatography. Phosphatidylcholine, neutral lipids, free fatty acids and traces of phosphatidylethanolamine were identified.
The form in which phosphorus was bound in fibrin prepared from purified fibrinogen was determined according to the procedure of Heald (1958) . The peak of the fraction containing organic phosphorus coincided with that obtained with an authentic specimen of O-phosphorylserine treated in a similar manner.
Fractionation procedures yielded only 20-30% of plasma fibrinogen. Further, there are some indications of inhomogeneity of human fibrinogen (Caspary & Kekwick, 1957; Mosesson & Finlayson, 1963) . For these reasons, in addition to purified fibrinogen, the 'cold insoluble residue' was analysed with the results given in Table 5 , which show that the phosphorus contents of the 'cold insoluble residue' and the fibrin clot obtained from it were 1-27-1-62 times those ofthe corresponding materials listed in Table 1 .
DISCUSSION
The heterogeneity of human fibrinogen has been consideredby Caspary & Kekwick (1957) . Mosesson & Finlayson (1963) separated by column chromatography two major types of human fibrinogen that differed in electrophoretic mobility but were identical in all other characteristics studied, including phosphorus content. The phosphorus content of plasma fibrin clots, 'cold insoluble residue', purified fibrinogens and fibrins derived from them have been compared in the present work. Although at appropriate plasma dilutions fibrin gave constant phosphorus values, on further dilution adsorption of lipoproteins was still demonstrable. Morrison (1947) observed that lipoproteins can be adsorbed by fibrin prepared from isolated fibrinogen. The ' cold insoluble residue' contained 75% of clottable protein. The phosphorus content of this fraction was 1-27-1-35 times that of purified fibrinogen, and this might indicate heterogeneity of plasma fibrinogen or co-precipitation of other plasma proteins containing phosphorus. With fibrinogen of high purity any phosphorus-containing contaminant must be of low molecular weight to affect significantly the phosphorus content. No evidence of appreciable adsorption of the phosphopeptide released during clotting (Blombaick, Blomback, Edman & Hessel, 1962) was observed. It is therefore concluded that phosphorus is a structural component of human fibrin. Hydrolysis experiments on fibrin obtained by clotting purified human fibrinogen indicated that phosphorus was bound as O-phosphorylserine.
One g.atom of phosphorus was present in 304 000-383 000g. (mean 342 000g.) of fibrinogen prepared from the plasma of each of ten persons, and in two other instances 1 g.atom of phosphorus was present in 265 000g. of fibrinogen. This could support the existence of different molecular species of fibrinogen in human plasma. Both the chemical determination of phosphorus and the radioactivity of 32P-labelled human fibrinogen and fibrin gave ratios of phosphorus in fibrinogen to that in fibrin 1-6-22, which were not altered by treatment with monochloroacetic acid and ethanol-ether extraction. These measures make the adsorption of water-soluble phosphorus compounds unlikely and indicate the absence of phospholipids in purified fibrinogen.
It is possible that the phosphorus content of both fibrinogen and fibrin could be decreased by proteolytic enzymes that may contaminate the preparations. Lower values were observed in a fibrinogen preparation that was dialysed for more than 2 days against 01 M-ammonium acetate, and also in a fibrinogen preparation that was isolated from the plasma of a donor who showed signs of stress during blood collection. These conditions can induce fibrinolysis.
In experiments in which 6-amino-n-hexanoic acid was present throughout the isolation procedure no difference in phosphorus content was obtained from those experiments in which it was absent (Table 1), indicating that fibrinolysis did not normally occur during the preparation.
The evidence presented points to an average molecular weight of human fibrinogen in the ten donors of Table 1 that cannot be lower than 342000. However, since 1g.atom of phosphorus was present in an average of 603 000g. of fibrin it is possible that thrombin splits off the phosphopeptide incompletely or that fibrinogen contains 2 phosphorus atoms/molecule, with a molecular weight of 684 000 from which thrombin splits the above phosphopeptide completely.
Values obtained for the molecular weight of human fibrinogen by physical techniques vary, as shown by the following published figures: 670000 (Holmberg, 1944; recalculated by Edsall, Foster & 
